Helen Valerhaugen
Overview
Explore the profile of Helen Valerhaugen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brunetti M, Andersen K, Spetalen S, Lenartova A, Osnes L, Valerhaugen H, et al.
Front Oncol
. 2024 Apr;
14:1371980.
PMID: 38571499
Introduction: Alterations of the gene (9q34) are recurrent in acute leukemias. Rearrangements of chromosomal band 9q34 targeting this locus can be karyotypically distinct, for example t(6;9)(p22;q34)/, or cryptic, in which...
2.
Floisand Y, Remberger M, Bigalke I, Josefsen D, Valerhaugen H, Inderberg E, et al.
Leukemia
. 2023 Jul;
37(9):1842-1849.
PMID: 37507426
Intensive induction chemotherapy achieves complete remissions (CR) in >60% of patients with acute myeloid leukemia (AML) but overall survival (OS) is poor for relapsing patients not eligible for allogeneic hematopoietic...
3.
Juul-Dam K, Ommen H, Nyvold C, Walter C, Valerhaugen H, Kairisto V, et al.
Br J Haematol
. 2020 Mar;
190(2):198-208.
PMID: 32175599
Serial assessments of measurable (or minimal) residual disease (MRD) by qPCR may identify nascent relapse in children with acute myeloid leukaemia (AML) and enable pre-emptive therapy. We investigated the kinetics...
4.
Juul-Dam K, Nyvold C, Valerhaugen H, Zeller B, Lausen B, Hasle H, et al.
Pediatr Blood Cancer
. 2019 Mar;
66(6):e27671.
PMID: 30900388
Background: Measurable/minimal residual disease (MRD) monitoring can predict imminent hematological relapse in acute myeloid leukemia (AML). The majority of childhood AML patients do not harbor fusion genes or mutations applicable...
5.
Ikonomou I, Tierens A, Troen G, Aamot H, Heim S, Lauritzsen G, et al.
Virchows Arch
. 2006 Apr;
449(1):78-87.
PMID: 16633785
Peripheral T-cell lymphoma (PTCL) with a nodular architecture is rare. Recently, two variants have been described with infiltration of the B-cell follicle, one variant that localizes to the marginal zone...